RegeneRx Biopharmaceuticals, Inc.
RGRX · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $1,993,910 | $2,217,488 | $6,467,815 | $1,833,594 |
| - Cash | $291 | $1,232 | $428 | $640 |
| + Debt | $1,446 | $1,165 | $1,026 | $735 |
| Enterprise Value | $1,995,065 | $2,217,421 | $6,468,413 | $1,833,689 |
| Revenue | $77 | $77 | $77 | $77 |
| % Growth | 0% | 0% | -0% | – |
| Gross Profit | $77 | $70 | $72 | $77 |
| % Margin | 100% | 91.4% | 93.6% | 99.9% |
| EBITDA | -$1,402 | $56 | -$1,290 | -$1,249 |
| % Margin | -1,826.2% | 73% | -1,680% | -1,627.1% |
| Net Income | -$1,727 | -$1,598 | -$1,523 | -$1,404 |
| % Margin | -2,249.8% | -2,081.8% | -1,984.1% | -1,829% |
| EPS Diluted | -1 | -0.014 | -0.013 | -0.012 |
| % Growth | -7,094.2% | -6.1% | -10.1% | – |
| Operating Cash Flow | -$941 | -$990 | -$1,007 | -$1,138 |
| Capital Expenditures | $0 | -$0 | $0 | $0 |
| Free Cash Flow | -$941 | -$990 | -$1,007 | -$1,138 |